Analysis of Mortality Rates from Cardiovascular Diseases in Different Regions of Panama and Associated Risk Factors

Abstract

Cardiovascular diseases are the leading cause of death in developed countries. The challenges faced by experts worldwide to halt the progression of what they already consider an epidemic are directed in four areas: prevention, diagnosis, treatment, and research. In this article, the author reviews some of the new perspectives in the treatment of cardiovascular system diseases. Many cardiac diseases are silent. 50% of males and 64% of females die suddenly due to heart disease, without prior warning. Experts believe that determining the risk as early and accurately as possible is crucial. In this context, it is essential to know who and why someone might have a heart attack. Part of the answer lies in our genes. Tracking the human genome to identify genes involved in heart diseases and developing a routine test to calculate a person's genetic sensitivity could be decisive in controlling these diseases. Understanding our genetic predisposition, reviewing patient habits, weight, blood pressure, and known risk factors such as cholesterol levels, among others, will enable doctors to determine more precisely and convincingly which patients need pharmacological treatment with statins, which patients only need to increase exercise, or which patients must definitively change their lifestyle before a cardiovascular episode occurs.